{"version":"1.0","provider_name":"AccuBoost","provider_url":"https:\/\/www.accuboost.com","author_name":"accuboost","author_url":"https:\/\/www.accuboost.com\/author\/accuboost\/","title":"AccuBoost announces Hypofractionated Accelerated Partial Breast Irradiation (APBI) trial for Non-Invasive Breast Brachytherapy (NIBB) - AccuBoost","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"smIXH276Jz\"><a href=\"https:\/\/www.accuboost.com\/media\/accuboost-announces-hypofractionated-accelerated-partial-breast-irradiation-apbi-trial-for-non-invasive-breast-brachytherapy-nibb\/\">AccuBoost announces Hypofractionated Accelerated Partial Breast Irradiation (APBI) trial for Non-Invasive Breast Brachytherapy (NIBB)<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.accuboost.com\/media\/accuboost-announces-hypofractionated-accelerated-partial-breast-irradiation-apbi-trial-for-non-invasive-breast-brachytherapy-nibb\/embed\/#?secret=smIXH276Jz\" width=\"600\" height=\"338\" title=\"&#8220;AccuBoost announces Hypofractionated Accelerated Partial Breast Irradiation (APBI) trial for Non-Invasive Breast Brachytherapy (NIBB)&#8221; &#8212; AccuBoost\" data-secret=\"smIXH276Jz\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/*! This file is auto-generated *\/\n!function(c,d){\"use strict\";var e=!1,o=!1;if(d.querySelector)if(c.addEventListener)e=!0;if(c.wp=c.wp||{},c.wp.receiveEmbedMessage);else if(c.wp.receiveEmbedMessage=function(e){var t=e.data;if(!t);else if(!(t.secret||t.message||t.value));else if(\/[^a-zA-Z0-9]\/.test(t.secret));else{for(var r,s,a,i=d.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),n=d.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),o=new RegExp(\"^https?:$\",\"i\"),l=0;l<n.length;l++)n[l].style.display=\"none\";for(l=0;l<i.length;l++)if(r=i[l],e.source!==r.contentWindow);else{if(r.removeAttribute(\"style\"),\"height\"===t.message){if(1e3<(s=parseInt(t.value,10)))s=1e3;else if(~~s<200)s=200;r.height=s}if(\"link\"===t.message)if(s=d.createElement(\"a\"),a=d.createElement(\"a\"),s.href=r.getAttribute(\"src\"),a.href=t.value,!o.test(a.protocol));else if(a.host===s.host)if(d.activeElement===r)c.top.location.href=t.value}}},e)c.addEventListener(\"message\",c.wp.receiveEmbedMessage,!1),d.addEventListener(\"DOMContentLoaded\",t,!1),c.addEventListener(\"load\",t,!1);function t(){if(o);else{o=!0;for(var e,t,r,s=-1!==navigator.appVersion.indexOf(\"MSIE 10\"),a=!!navigator.userAgent.match(\/Trident.*rv:11\\.\/),i=d.querySelectorAll(\"iframe.wp-embedded-content\"),n=0;n<i.length;n++){if(!(r=(t=i[n]).getAttribute(\"data-secret\")))r=Math.random().toString(36).substr(2,10),t.src+=\"#?secret=\"+r,t.setAttribute(\"data-secret\",r);if(s||a)(e=t.cloneNode(!0)).removeAttribute(\"security\"),t.parentNode.replaceChild(e,t);t.contentWindow.postMessage({message:\"ready\",secret:r},\"*\")}}}}(window,document);\n<\/script>\n","thumbnail_url":"https:\/\/www.accuboost.com\/wp-content\/uploads\/2018\/01\/news_graphic.jpg","thumbnail_width":800,"thumbnail_height":533,"description":"[et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;3.22&#8243;][et_pb_row _builder_version=&#8221;3.25&#8243;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;3.25&#8243; custom_padding=&#8221;|||&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_image src=&#8221;https:\/\/www.accuboost.com\/wp-content\/uploads\/2014\/10\/AccuBoost_press-header.png&#8221; align_tablet=&#8221;center&#8221; align_last_edited=&#8221;on|desktop&#8221; _builder_version=&#8221;3.23&#8243; always_center_on_mobile=&#8221;on&#8221;][\/et_pb_image][et_pb_post_title author=&#8221;off&#8221; featured_image=&#8221;off&#8221; _builder_version=&#8221;3.0.100&#8243;][\/et_pb_post_title][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;3.25&#8243; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;3.25&#8243; custom_padding=&#8221;|||&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_text _builder_version=&#8221;3.27.4&#8243;]Advanced Radiation Therapy, creators of the AccuBoost Breast Brachytherapy technology, is pleased to announce that the Brown University Oncology Research Group (BrUOG) has launched a new multicenter NIBB APBI clinical trial [&hellip;]"}